CH

Catella Healthcare Investments

Europe, Stockholms Lan, Sweden, Stockholm

Description

Catella Healthcare Investments is a Swedish investment firm that offers middle and late stage investments.

Investor Profile

Catella Healthcare Investments has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series E, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series E (50%)
  • Series Unknown (50%)

Country Focus

  • United States (50%)
  • Sweden (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Catella Healthcare Investments frequently co-invest with?

Thomas Weisel Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 1
HB Ventures
Asia, Beijing, China, Gaobeidian
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Hercules Capital
North America, California, United States, San Mateo
Co-Investments: 1
BV
North America, California, United States, San Diego
Co-Investments: 1
TL Ventures
North America, Pennsylvania, United States, Wayne
Co-Investments: 1
SC
North America, Texas, United States, Austin
Co-Investments: 1

What are some of recent deals done by Catella Healthcare Investments?

QuatRx Pharmaceuticals

Ann Arbor, Michigan, United States

QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds

BiotechnologyHealth CarePharmaceutical
Series EMay 22, 2007
Amount Raised: $44,000,000
Cellartis

Göteborg, Vastra Gotaland, Sweden

Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.

Biotechnology
Series UnknownDec 13, 2005
Amount Raised: $9,553,414

Find More Investors Like Catella Healthcare Investments

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Catella Healthcare Investments | Pipeseed